v1.0.5 is the second stabilization release in the v1.0.x arc. With test infrastructure in place from v1.0.4, this release focuses on data integrity across the platform — programmatic audits that verify correctness of SQL generation, schema routing, vocabulary resolution, FHIR transformation, migration safety, and cross-schema referential integrity.
Every research platform hits the same inflection point. You build a powerful cohort builder. Researchers love it. They create cohorts for Study 1, Study 2, the rare disease project, the pancreatic cancer corpus. Each study gets its own "All-Cause Death" outcome. Each gets its own "MACE" composite endpoint. Before long, you're staring at 89 cohort definitions in a flat, unsorted list where a meticulous seven-concept-set new-user design sits next to an auto-generated stub with one concept and no generations. A Rett syndrome genotype-stratified trial cohort is sandwiched between a SynPUF cardiometabolic triad and a never-run hypertension bundle. The list is technically complete and practically useless.
Today, Parthenon ships a cohort categorization system that solves this. We audited every cohort definition in the database, identified and consolidated 9 duplicates and orphans, assigned 80 surviving cohorts to 8 clinical domains, computed a quality tier for each one, and rebuilt the Cohort Definitions page with collapsible domain-grouped sections and quality filter pills. Researchers can now browse by clinical domain, filter to study-ready phenotypes, and find what they need in seconds instead of scrolling through a flat table.
This post describes the problem in detail, explains how we analyzed and scored the inventory, walks through the architecture, and shows what the result looks like.
If you've worked in the OHDSI ecosystem, you know the pain: Atlas for cohort definitions, Achilles Results Viewer for characterization, a DQD dashboard for data quality, spreadsheets for feasibility assessments, and a prayer that everyone's looking at the same release of the same data. Ares changes that. Today we're announcing Ares v2 — Parthenon's network-level data observatory — a single unified module that replaces the fragmented constellation of OHDSI data characterization tools with 10 purpose-built analytical panels, 60+ API endpoints, and a clinical UI designed for researchers who need answers, not workarounds.
This is the biggest feature release in Parthenon's history.
Abby now understands that metformin is a drug used for Type 2 diabetes mellitus, which is a subtype of diabetes mellitus. She traverses OMOP concept hierarchies, finds siblings and related concepts, and warns researchers when they're building on sparse data. Phase 3 turns keyword matching into relational understanding.